SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-020246
Filing Date
2022-05-16
Accepted
2022-05-16 06:45:41
Documents
82
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-10q_20220331.htm   iXBRL 10-Q 2186849
2 EX-10.1 syrs-ex101_36.htm EX-10.1 664645
3 EX-31.1 syrs-ex311_8.htm EX-31.1 17970
4 EX-31.2 syrs-ex312_7.htm EX-31.2 17932
5 EX-32.1 syrs-ex321_6.htm EX-32.1 5981
6 EX-32.2 syrs-ex322_10.htm EX-32.2 5931
  Complete submission text file 0001564590-22-020246.txt   10560601

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA syrs-20220331.xsd EX-101.SCH 74341
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20220331_cal.xml EX-101.CAL 60966
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20220331_def.xml EX-101.DEF 252548
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20220331_lab.xml EX-101.LAB 545616
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20220331_pre.xml EX-101.PRE 447258
76 EXTRACTED XBRL INSTANCE DOCUMENT syrs-10q_20220331_htm.xml XML 1988326
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 22925338
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences